skip to main | skip to sidebar

advanced medical technologies

Notes, comments, insights and data on medical technology developments, implications in the marketplace and the players who are driving them. From Patrick Driscoll, Publisher of MedMarkets and President of MedMarket Diligence, LLC.

Thursday, April 08, 2010

Tissue Engineering and Cell Therapy 2009-2018

Tissue Engineering and Cell Therapy 2009-2018
Posted by P. Driscoll at 7:08 AM 0 comments Links to this post
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

MedMarket Diligence Reports

  • Ablation Technologies Worldwide, 2008-2017
  • Spine Surgery Worldwide, 2008-2017
  • Worldwide Wound Management

Followers

Blog Archive

  • ▼  2010 (1)
    • ▼  April (1)
      • Tissue Engineering and Cell Therapy 2009-2018
  • ►  2007 (3)
    • ►  January (3)
      • This blog has moved
      • Amniotic stem cells good, but not embryonic replac...
      • Medtech Startups: Stealth, Location, and Platform ...
  • ►  2006 (55)
    • ►  December (2)
      • FDA Panel Assesses Drug-Eluting Stents and Clottin...
      • Orthopedic Biomaterials Global Market
    • ►  November (3)
      • Global Growth in Refractive Surgery
      • Orthopedic Biomaterials Market Segment Growth
      • Drug-Eluting and Bioabsorbable Stents
    • ►  October (2)
      • Can We Handle the Pace of Technology Development?
      • Technologies and that Highlight Advances and Preci...
    • ►  September (3)
      • Startup Medtech Companies, September 2006
      • U.S. diabetes prevalence to double by 2050
      • Bioengieering the end of medical devices (well, ev...
    • ►  August (5)
      • The Intellectual Property Yardstick
      • Medtech analysis test drive
      • Energy-Based Devices in General Surgery
      • August 2006 startup medtech companies
      • Biomaterials Stimulating Orthpedic Growth
    • ►  July (7)
      • Artificial Pancreas for Diabetes: The Closed Loop...
      • Local Market Volume of Medical/Surgical Procedures...
      • Top Volume Hospitals by DRG, ICD-9
      • Technologies in Treatment of Stress Urinary Incont...
      • Spine Surgery Market Development at a Pivotal Stag...
      • Timescale of nanotechnology materials/components a...
      • Drug delivery and nanotech
    • ►  June (6)
      • Endovascular Technologies Drive AAA and TAA Stent-...
      • Meanwhile, American Medical Systems Corners a Mark...
      • Megatrends in Medical Technology
      • Categories on medtech companies tracked
      • Wasted Medicine: A Mantra
      • Guidant Warning Letter Never Sent Over Concern of ...
    • ►  May (7)
      • MEMS and Nanotech in Medicine
      • Unnecessary Surgery and Throwing the Baby Out with...
      • "Medical Guesswork" Exposing the Ugly Truth
      • Endoscopic GERD Treatment
      • Nanotech Hype versus Actual
      • Organ Printing
      • Diabetes complications
    • ►  April (12)
      • Cardiovascular Drug-Eluting Stent Developers, Prod...
      • More Drug-Eluting Stents Nearing Market; Biotech M...
      • High Growth Medical Technologies -- Add'l Opportun...
      • CMS Medicare Cuts for Cardiac Devices Won't Fly (T...
      • Nanotech/MEMS in medicine (nanomedicine) companies...
      • Drug-Eluting Stents Update; plus Biotech Progress ...
      • High growth medical technologies
      • Diabetes markets (Type I & II)
      • Bioengineered bladders
      • Startup Medtech Companies
      • advanced MEDICAL technologies
    • ►  March (4)
    • ►  January (4)
  • ►  2005 (11)
    • ►  December (4)
    • ►  November (7)

Links

  • About MedMarkets
  • MedMarkets 2006 coverage
  • Medical technology reports

About Me

My Photo
P. Driscoll
Adversity is opportunity.
View my complete profile